论文部分内容阅读
目的观察凯时联合克林澳治疗糖尿病周围神经病变的疗效。方法将诊断明确的2型糖尿病周围神经病变患者92例随机分为3组,3组均常规治疗。I组30例,加用克林澳治疗,每日用克林澳注射液320mg加入生理盐水250ml静脉滴注,1次/d;Ⅱ组30例,加用凯时注射液10μg加入生理盐水20ml静脉推注,1次/d;Ⅲ组32例,加用凯时联合克林澳治疗,凯时注射液10μg加入生理盐水20ml静脉推注,1次/d,同时每日克林澳注射液320mg加入生理盐水250ml静脉滴注,1次/d,共4周。结果3组对神经症状体征均有显著改善(P<0.01),而Ⅲ组的疗效明显优于I、Ⅱ组(P<0.05)。结论凯时联合克林澳治疗糖尿病周围神经病变有较好的疗效,安全可靠。
Objective To observe the curative effect of combination of Kaylin and Diabetes on diabetic peripheral neuropathy. Methods 92 patients with diagnosed type 2 diabetic peripheral neuropathy were randomly divided into 3 groups, 3 groups were routinely treated. Group I 30 cases, plus the use of Kelin O treatment daily with Kelin O injection 320mg saline 250ml intravenous infusion, 1 / d; Ⅱ group of 30 cases, plus Kai Shi injection 10μg saline 20ml Intravenous injection, 1 time / d; 32 patients in group Ⅲ, combined with Kay when combined with Clinopril treatment, Kai Shi injection 10μg saline 20ml intravenous injection, 1 time / d, while daily Klin O. injection 320mg saline 250ml by intravenous infusion, 1 time / d, a total of 4 weeks. Results The neurological symptoms and signs were significantly improved in all three groups (P <0.01), while those in group Ⅲ were significantly better than those in groups I and II (P <0.05). Conclusions Kay when combined with Kelin O treatment of diabetic peripheral neuropathy has a good effect, safe and reliable.